Robotic prostatectomy offers equivalent cancer control to open surgery with significantly less blood loss, shorter hospital stay, faster recovery, and — in experienced hands — better outcomes for continence and erectile function.
When prostate cancer is diagnosed and surgery is the chosen treatment, the question immediately arises: which approach? Your surgeon may have recommended one or the other, or you may have heard about robotic surgery and are wondering whether it offers any real advantage.
The honest answer is nuanced. Robotic surgery offers real advantages in recovery, blood loss, and — in experienced hands — functional outcomes. But the surgeon's experience matters as much as the platform. This article gives you the evidence to understand the differences.
1. What is open prostatectomy?
Open radical prostatectomy (ORP) involves a single incision from the belly button to the pubic bone. The surgeon operates directly through this incision with their hands and conventional instruments. Performed since the 1980s, it has an established long-term track record for cancer control.
Open surgery remains a valid and effective option — particularly in centres where robotic surgery is not available, or in very obese patients where robotic access has limitations. The cancer removal is equivalent. The differences lie in recovery and functional outcomes.
2. What is robotic prostatectomy?
Robot-Assisted Radical Prostatectomy (RARP) uses the da Vinci surgical system — the surgeon controls robotic arms from a console, operating through 5–6 keyhole incisions of 8–12mm. The robotic system provides 3D stereoscopic magnification (up to 10x), tremor filtering, and articulating instruments (EndoWrist) that replicate the full range of human wrist motion inside the narrow pelvis.
The prostate gland is removed in an identical fashion to open surgery, but through a completely different route that avoids a large incision.
3. Head-to-head comparison
- 10–15 cm midline incision
- Average blood loss 500–1500 mL
- Transfusion rate 10–20%
- Hospital stay 4–7 days
- Catheter 10–14 days
- Return to work 6–8 weeks
- Surgeons widely trained
- 5–6 keyhole incisions (8–12mm)
- Average blood loss 100–300 mL
- Transfusion rate <2%
- Hospital stay 1–2 days
- Catheter 7–10 days
- Return to work 2–4 weeks
- Requires specialised training
4. Cancer control outcomes
The primary objective of any radical prostatectomy is complete cancer removal — specifically, achieving negative surgical margins (no cancer cells at the cut edge of the specimen).
Multiple large studies and meta-analyses have consistently shown that positive surgical margin rates are comparable between robotic and open surgery in experienced hands. Neither approach has a proven oncological superiority over the other in terms of long-term cancer control, biochemical recurrence, or cancer-specific survival.
The single most important predictor of surgical margin status and functional outcomes is the surgeon's experience — not the platform. A high-volume open surgeon outperforms a low-volume robotic surgeon. When choosing treatment, ask about annual surgical volume, not just the technology used.
5. Functional outcomes — continence and erections
Where robotic surgery shows a clearer advantage is in functional outcomes — urinary continence recovery and erectile function preservation. This is where the 3D magnification and precision of the robotic platform make a tangible difference.
Urinary continence
Multiple studies show faster continence recovery following RARP versus ORP. At 3 months post-surgery, robotic patients are typically using fewer pads. By 12 months, rates converge — but the speed of recovery is meaningfully better with the robotic approach in most analyses.
Erectile function
Nerve-sparing surgery — the delicate dissection of the neurovascular bundles responsible for erection — is significantly facilitated by the magnification and precision of the robotic platform. The ability to see and preserve these structures is considerably enhanced compared to open surgery. Studies show higher nerve-sparing rates and better erectile function recovery with RARP in experienced centres.
6. Who benefits most from robotic surgery?
- Younger, sexually active men — where preservation of erectile function is a high priority
- Men prioritising rapid recovery — returning to work or active life sooner
- Patients with large or awkward prostates — robotic instruments navigate better in the pelvis
- High-risk disease where nerve-sparing is complex — precision matters more in difficult dissections
- Men who have had prior pelvic surgery or radiation — adhesions can be handled more precisely robotically
Open surgery remains a valid choice in centres where robotic surgery is unavailable, for very obese patients (where Trendelenburg positioning for robotic access is physiologically difficult), and when surgeon experience is significantly greater with the open approach.
- How many prostatectomies do you perform per year — open and robotic?
- What is your positive margin rate by tumour stage?
- What is your continence rate at 3 and 12 months?
- Is nerve-sparing feasible in my case — on both sides?
- Is robotic surgery available at your centre — and if not, where would you refer me?
- What are the alternatives to surgery — radiation with hormone therapy, focal therapy?
This article is for general patient education and does not constitute personalised medical advice. The optimal surgical approach depends on individual tumour characteristics, patient factors, and surgeon experience. Discuss all options thoroughly with your treating urologist.